Supporting Expectant Mothers With ADHD Through the Transition to Parenthood: A Pilot RCT

What this Trial Is About

This research aims to evaluate a behavioral program called MomMA for pregnant individuals with ADHD. The study focuses on managing ADHD symptoms during pregnancy and postpartum to improve parent and child well-being, parent-child interactions, and reduce risks of child mental health disorders. It is a pilot randomized controlled trial comparing the MomMA intervention to treatment as usual (TAU) and also examines how well the intervention can be implemented in real-world healthcare settings. The trial includes 40 pregnant women with ADHD, randomly assigned to either the MomMA behavioral intervention or TAU. The MomMA program is a cognitive-behavioral therapy (CBT) based intervention tailored for expectant parents with ADHD, delivered by therapists within obstetric care settings. The TAU group may receive various treatments, including medication or behavioral therapy, but no specific intervention is required. The study will assess acceptability, feasibility, and fidelity of the intervention and protocols. Participants will be evaluated at around 36 weeks gestational age and again 4-5 months postpartum. Researchers will measure outcomes such as ADHD symptom severity, functional impairment, mood and distress, parent-child attachment, infant behavior, home environment, and parent-child interactions. The study also tracks changes in executive function and emotion regulation to understand how these relate to clinical outcomes. The total study period covers pregnancy and early postpartum months, with assessments conducted by trained providers.

Expectant Moms Managing Attention-Deficit/ Hyperactivity Disorder